The Immunomodulatory Roles of Extracellular Vesicles in the Pathogenesis of Virus-Related Cancers

Since their discovery in the 1980s, extracellular vesicles (EVs) have garnered immense interest. These vesicles facilitate cell-to-cell communication and transfer physiologically active molecules such as proteins, lipids, and RNAs to target cells. Oncogenic viruses encode genes that enable viral replication and allow host cells to produce viral proteins and complexes. These viral components represent potential candidates for developing antiviral therapies or vaccines. Exosomes, a type of EV, can enhance immune responses by delivering immunostimulatory molecules and inhibiting viral replication. However, oncoviruses can also exploit the diverse immunoregulatory functions of exosomes to promote disease progression. This review focuses on the dual role of EVs produced during viral infections, examining how they can either enhance or suppress host immunity. We provide an overview of the function of exosomes in oncogenic virus infections, with a particular emphasis on their immunosuppressive and immunomodulatory potential. We also highlight challenges in harnessing these vesicles for advanced cancer theranostics and preventive strategies.

Authors

Institutions

Publication Details

Journal
Viral Immunology
Published
2026-01-13
DOI
https://doi.org/10.1177/08828245251413728
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Immunomodulatory Roles of Extracellular Vesicles in the Pathogenesis of Virus-Related Cancers

Reza Jafari, Fatah Kashanchi, Sima Heidarzadeh-Asl
Viral Immunology
Extracellular vesicles in disease
article

The Immunomodulatory Roles of Extracellular Vesicles in the Pathogenesis of Virus-Related Cancers

Reza Jafari, Fatah Kashanchi, Sima Heidarzadeh-Asl
article en

Abstract

Since their discovery in the 1980s, extracellular vesicles (EVs) have garnered immense interest. These vesicles facilitate cell-to-cell communication and transfer physiologically active molecules such as proteins, lipids, and RNAs to target cells. Oncogenic viruses encode genes that enable viral replication and allow host cells to produce viral proteins and complexes. These viral components represent potential candidates for developing antiviral therapies or vaccines. Exosomes, a type of EV, can enhance immune responses by delivering immunostimulatory molecules and inhibiting viral replication. However, oncoviruses can also exploit the diverse immunoregulatory functions of exosomes to promote disease progression. This review focuses on the dual role of EVs produced during viral infections, examining how they can either enhance or suppress host immunity. We provide an overview of the function of exosomes in oncogenic virus infections, with a particular emphasis on their immunosuppressive and immunomodulatory potential. We also highlight challenges in harnessing these vesicles for advanced cancer theranostics and preventive strategies.

Viral ImmunologyVol. 39(2)
Razi Vaccine and Serum Research Institute (IR), George Mason University (US), Urmia University (IR), Agricultural Research & Education Organization (IR), Urmia University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 89%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.